SCHEMBL4283430

SCHEMBL4283430

Fc1cccc([CH]C2CCC2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 8/20 0.52
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
PKM P14618 1/20 0.47
MAPK1 P28482 1/20 0.47
THPO P40225 1/20 0.47
NPC1 O15118 1/20 0.47
CHRM5 P08912 1/20 0.47
GRM5 P41594 1/20 0.47
RAB9A P51151 1/20 0.47
BLM P54132 1/20 0.47
PMP22 Q01453 1/20 0.47
PTGS1 P23219 2/20 0.42
PTGS2 P35354 1/20 0.42
MAOA P21397 2/20 0.41
MAOB P27338 2/20 0.41
IKBKB O14920 1/20 0.41
FGFR1 P11362 1/20 0.41
NQO2 P16083 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2676216 0.92 NFE2L2 (0.56) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL493382 0.80 BPTF (0.44) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL1119433 0.74 ALDH1A1 (0.42) CYP1A2CYP2D6MAOB
SCHEMBL1396911 0.74 NFE2L2 (0.44) NFE2L2CYP1A2CYP3A4CYP2D6PKM
Cyclohexane SCHEMBL268585 0.74 NFE2L2 (0.58) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL652509 0.71 NPC1 (0.42) NFE2L2NPC1RAB9AMAOAMAOB
Cyclohexylamine SCHEMBL7800228 0.70 TP53 (0.45) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL316481 0.70 POLB (0.45) MAPK1MAOB
SCHEMBL29359478 0.70
SCHEMBL1574019 0.70 NFE2L2 (0.65) NFE2L2CYP1A2CYP3A4CYP2D6PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102123998-A Isoquinolinone derivatives as nk3 antagonists LUNDBECK & CO AS H 2011-07-13 CN disclosed
WO-2009156339-A1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS H. LUNDBECK A/S (DK) 2009-12-30 WO disclosed